Connecticut Senate Bill SB00810

Connecticut 2017 Regular Session

• Introduced: 2/15/17
• Refer: 2/15/17
• Report Pass: 3/7/17

Caption

An Act Redefining Mammogram And Eliminating Cost-sharing For Mammograms, Breast Ultrasounds And Magnetic Resonance Imaging Of Breasts.

Impact

The implementation of SB00810 is projected to significantly enhance access to breast cancer screening for women in the state, particularly for those aged 35 to 39 who will be provided a baseline mammogram, as well as annual mammograms for those aged 40 and older. By removing cost-sharing elements, the bill supports early detection of breast cancer, potentially leading to better health outcomes for women. The requirement for reporting breast density information in mammography reports will also help healthcare providers offer tailored advice on supplementary screening tests.

Summary

Substitute Bill No. 810 aims to redefine the term 'mammogram' within state statutes and eliminate any cost-sharing required for mammograms, breast ultrasounds, and magnetic resonance imaging (MRI) for breasts. This legislation is intended to ensure that all women covered under individual and group health insurance policies in the state receive appropriate screening without the burden of out-of-pocket expenses. The bill identifies the types of mammographic examinations and sets specific requirements for insurance providers regarding coverage for women based on their age and individual risk factors.

Sentiment

The sentiment surrounding SB00810 appears to be largely positive among lawmakers and community advocates who support increased access to breast cancer screenings. The bill's unanimous passage (20-0) in the voting reflects broad bipartisan support for its objectives, indicating a collective agreement on the importance of health interventions aimed at reducing the incidence of breast cancer through better screening methodologies. However, some concerns regarding healthcare costs and insurance provider reactions could influence future discussions around the sustainability of such mandates.

Contention

Despite widespread support, ongoing discussions may face challenges related to the financial implications for insurance companies tasked with absorbing the costs of mandated screenings. Concerns have been raised about the potential increasing enrollment in high-deductible health plans, which may complicate patient access to these services under the new provisions. The balance between ensuring comprehensive coverage and managing insurance premiums will continue to be a point of contention as the ramifications of SB00810 unfold in the healthcare market.